Search

everythinglearnresearchcommunity

for

Search:↓

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

p2y5, now called LPA6, is a receptor important for human hair growth.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Mutations in the hairless gene cause hair loss and skin cysts in rhesus macaques.

The method accurately measures Tamsulosin and Finasteride in medication and is suitable for regular quality checks.

A new genetic mutation in the hairless gene causes a rare hair loss disorder.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

The PHAT technique effectively rejuvenates lips and face.

Pax9 is crucial for proper tongue surface development and preventing skin-like changes.

The document's conclusion cannot be provided as the content is not available for parsing.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

FFA patients have higher metal levels in hair, possibly linked to product use.

18-MEA is essential for hair's water resistance, and a conditioner with 18-MEA and SPDA can restore it.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Acetyl tetrapeptide-3 was successfully made for use in hair loss treatments.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

A married couple both developed a rare type of hair loss, possibly due to shared environmental factors.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.